Abbott Laboratories (ABT) Intangibles (2009 - 2026)

Abbott Laboratories has disclosed Intangibles across 18 years of filings, most recently posting $17.9 billion for Q1 2026.

• Intangibles for Q1 2026 came in at $17.9 billion, up 185.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $17.9 billion (up 185.5% YoY), and the FY2025 annual result was $5.5 billion, down 16.86% from the prior year.
• Intangibles came in at $17.9 billion for Q1 2026 at Abbott Laboratories, up from $5.5 billion in the prior quarter.
• In the past five years, Intangibles ranged from a high of $17.9 billion in Q1 2026 to a low of $5.5 billion in Q4 2025.
• The 5-year median for Intangibles is $8.8 billion (2023), against an average of $9.1 billion.
• Peak annual rise in Intangibles reached 8246.15% in 2022, while the deepest fall reached 58.3% in 2022.
• Abbott Laboratories' Intangibles stood at $10.5 billion in 2022, then declined by 15.68% to $8.8 billion in 2023, then slipped by 24.59% to $6.6 billion in 2024, then decreased by 16.86% to $5.5 billion in 2025, then soared by 223.47% to $17.9 billion in 2026.
• The last three Intangibles figures came in at $17.9 billion (Q1 2026), $5.5 billion (Q4 2025), and $5.6 billion (Q3 2025), per Business Quant data.